Arachidonic Acid
In clinical developmentAlso known as vitamin F.
Recent clinical, regulatory, research and industry developments relating to this drug.
The Role of Fatty Acids in Vaccine Efficacy: A Randomized Controlled Clinical Trial
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes1
Journals, researchers & institutions
- International journal of molecular sciences1
- Journal of neuroinflammation1
- Barros PL1
- Bydlowski SP1
- de Freitas FA1
- Hwang SW1
- Jang Y1
- Kim M1
- Levy D1
- Reichert CO1
- College of Medicine1
- Hanyang University1
- Instituto Nacional de Ciencia e Tecnologia em Medicina Regenerativa (INCT-Regenera)1
- Korea University1
- Laboratory of Immunology (LIM19)1
- McLean Hospital1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Arachidonic Acid in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials